These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Reduction of the mortality rate by imidapril in a small coronary artery disease model, (NZW x BXSB)F1 male mice. Ogiku N; Sumikawa H; Nishimura T; Narita H; Ishida R Jpn J Pharmacol; 1994 Feb; 64(2):129-33. PubMed ID: 8028230 [TBL] [Abstract][Full Text] [Related]
4. Different potentiating effects of imidapril and enalapril on kaolin-induced writhing reaction in mice. Sakamoto K; Sugimoto K; Fujimura A Life Sci; 2001 Apr; 68(21):2415-21. PubMed ID: 11350012 [TBL] [Abstract][Full Text] [Related]
5. Steady-state pharmacokinetics and pharmacodynamics of imidaprilat, an active metabolite of imidapril, a new angiotensin-converting enzyme inhibitor in spontaneously hypertensive rats. Yamanaka K; Takehara N; Murata K; Banno K; Sato T J Pharm Sci; 1996 Nov; 85(11):1234-7. PubMed ID: 8923331 [TBL] [Abstract][Full Text] [Related]
6. Dose-dependent effects of angiotensin converting enzyme (ACE) inhibitors on glomerular prostanoid production by normotensive rats. Harding P; Stonier C; Aber GM Br J Pharmacol; 1993 Feb; 108(2):327-30. PubMed ID: 8448584 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of beta adrenoceptor antagonist, atenolol, on the thromboxane system in the kidney of spontaneously hypertensive rats. Hirawa N; Uehara Y; Numabe A; Ikeda T; Yagi S; Sugimoto T; Ishii M Prostaglandins Leukot Essent Fatty Acids; 1991 Jun; 43(2):93-8. PubMed ID: 1886913 [TBL] [Abstract][Full Text] [Related]
8. Different effects of imidapril and enalapril on aminopeptidase P activity in the mouse trachea. Sakamoto K; Sugimoto K; Sudoh T; Fujimura A Hypertens Res; 2005 Mar; 28(3):243-7. PubMed ID: 16097368 [TBL] [Abstract][Full Text] [Related]
9. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs. Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673 [TBL] [Abstract][Full Text] [Related]
10. Effect of angiotensin-converting enzyme inhibitor (enalapril or imidapril) on ventilation during exercise in patients with chronic heart failure secondary to idiopathic dilated cardiomyopathy. Kitaoka H; Takata J; Hitomi N; Furuno T; Seo H; Chikamori T; Doi YL Am J Cardiol; 2000 Mar; 85(5):658-60, A10. PubMed ID: 11078286 [TBL] [Abstract][Full Text] [Related]
11. Additive effects of losartan and enalapril on blood pressure and plasma active renin. Azizi M; Guyene TT; Chatellier G; Wargon M; Ménard J Hypertension; 1997 Feb; 29(2):634-40. PubMed ID: 9040450 [TBL] [Abstract][Full Text] [Related]
12. Studies on the magnitude and the mechanism of cough potentiation by angiotensin-converting enzyme inhibitors in guinea-pigs: involvement of bradykinin in the potentiation. Takahama K; Araki T; Fuchikami J; Kohjimoto Y; Miyata T J Pharm Pharmacol; 1996 Oct; 48(10):1027-33. PubMed ID: 8953504 [TBL] [Abstract][Full Text] [Related]
13. Imidapril, an angiotensin-converting enzyme inhibitor, improves insulin sensitivity by enhancing signal transduction via insulin receptor substrate proteins and improving vascular resistance in the Zucker fatty rat. Nawano M; Anai M; Funaki M; Kobayashi H; Kanda A; Fukushima Y; Inukai K; Ogihara T; Sakoda H; Onishi Y; Kikuchi M; Yazaki Y; Oka Y; Asano T Metabolism; 1999 Oct; 48(10):1248-55. PubMed ID: 10535386 [TBL] [Abstract][Full Text] [Related]
14. Dose-dependent inhibition of angiotensin converting enzyme by enalapril in cats. Uechi M; Imamoto S; Ishikawa Y J Vet Med Sci; 2002 Apr; 64(4):385-7. PubMed ID: 12014588 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the incidence of imidapril and enalapril induced cough. Boonyapisit W; Tresukosol D J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S48-53. PubMed ID: 20364557 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities. Kubo M; Kato J; Ochiai T; Ishida R Jpn J Pharmacol; 1990 Jun; 53(2):201-10. PubMed ID: 2200918 [TBL] [Abstract][Full Text] [Related]
17. Toxicodynamic analysis of cough and inflammatory reactions by angiotensin-converting enzyme inhibitors in guinea pig. Ito K; Ito K; Sawada Y; Kamei J; Misawa M; Iga T J Pharmacol Exp Ther; 1995 Nov; 275(2):920-5. PubMed ID: 7473183 [TBL] [Abstract][Full Text] [Related]
18. Importance of secondary TXA2 release in mediating of endothelin-1 induced bronchoconstriction and vasopressin in the guinea-pig. Lueddeckens G; Bigl H; Sperling J; Becker K; Braquet P; Förster W Prostaglandins Leukot Essent Fatty Acids; 1993 Mar; 48(3):261-3. PubMed ID: 8469685 [TBL] [Abstract][Full Text] [Related]
19. [Effect of captopril on platelet cytosolic [Ca2+]i and plasma TXA2/PGI2 in renovascular hypertensive rats]. Wei XR; Hu L; Du J Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):89-91. PubMed ID: 10375769 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the effect of imidaprilat and ramiprilat on broncho-constriction and hypotension induced by bradykinin in guinea pigs. Doi H; Narita H Inflamm Res; 2000 Oct; 49(10):506-12. PubMed ID: 11089901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]